Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development
Open Access
- 5 July 2010
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 3 (7), 2090-2110
- https://doi.org/10.3390/ph3072090
Abstract
Epilepsy is a serious neurological disorder that affects around 50 million people worldwide. Almost 30% of epileptic patients suffer from pharmacoresistance, which is associated with social isolation, dependent behaviour, low marriage rates, unemployment, psychological issues and reduced quality of life. Currently available antiepileptic drugs have a limited efficacy, and their negative properties limit their use and cause difficulties in patient management. Antiepileptic drugs can provide only symptomatic relief as these drugs suppress seizures but do not have ability to cure epileptogenesis. The long term use of antiepileptic drugs is limited due to their adverse effects, withdrawal symptoms, deleterious interactions with other drugs and economic burden, especially in developing countries. Furthermore, some of the available antiepileptic drugs may even potentiate certain type of seizures. Several in vivo and in vitro animal models have been proposed and many new antiepileptic drugs have been marketed recently, but large numbers of patients are still pharmacoresistant. This review will highlight the difficulties in treatment and management of epilepsy and the limitations of available antiepileptic drugs and animal seizure models.This publication has 162 references indexed in Scilit:
- Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence EpilepsyThe New England Journal of Medicine, 2010
- The descriptive epidemiology of epilepsy—A reviewEpilepsy Research, 2009
- Challenges in the management of epilepsy in resource-poor countriesNature Reviews Neurology, 2009
- The pilocarpine model of temporal lobe epilepsyJournal of Neuroscience Methods, 2008
- Teratogenicity of Antiepileptic MedicationsSeminars in Neurology, 2008
- Intractable epilepsy: management and therapeutic alternativesThe Lancet Neurology, 2008
- Standard antiepileptic drugs fail to block epileptiform activity in rat organotypic hippocampal slice culturesBritish Journal of Pharmacology, 2008
- Choosing the Correct Antiepileptic Drugs: From Animal Studies to the ClinicPediatric Neurology, 2008
- Technology Insight: neuroengineering and epilepsy—designing devices for seizure controlNature Clinical Practice Neurology, 2008
- Gestational Age, Birth Weight, Intrauterine Growth, and the Risk of EpilepsyAmerican Journal of Epidemiology, 2007